Listed by the USPTO as GRAY, JESSICA
Tech Center 1600 • Art Units: 1682 1683
This examiner grants 0% of resolved cases
GRAY, JESSICA has resolved 13 cases in Tech Center 1600 and Art Unit 1682. The allowance rate and interview lift are both 0.0%, while the median time to allowance is 1370 days. The small resolved-case record limits the predictive value of the percentages, so the profile should be treated as a narrow historical reference.
The associated companies are The Board of Trustees of the Leland Stanford Junior University, 10x Genomics Inc., and Illumina Inc. The associated firms are Casimir Jones, S.C., pH IP Law, and WILSON SONSINI GOODRICH & ROSATI. Counsel can use these names to identify related technology and representation experience, while basing substantive decisions on the application-specific record.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17997905 | PREDICTING RESPONSE TO PD-1 AXIS INHIBITORS | Final Rejection | Hoffmann-La Roche Inc. |
| 17506804 | NUCLEIC ACID DETECTION SYSTEM AND NUCLEIC ACID DETECTION METHOD | Non-Final OA | Canon Kabushiki Kaisha |
| 18431793 | METHODS AND COMPOSITIONS FOR DETECTION USING NUCLEIC ACID PROBES | Final Rejection | 10x Genomics, Inc. |
| 18018101 | DE-CROSSLINKING COMPOUNDS AND METHODS OF USE FOR SPATIAL ANALYSIS | Final Rejection | 10x Genomics, Inc. |
| 18712422 | METHODS AND COMPOSITIONS RELATED TO INFLAMMATORY GENE PANEL | Non-Final OA | Ohio State Innovation Foundation |
| 18289455 | METHODS FOR DETECTING DYSFUNCTIONAL NK CELLS IN LEUKEMIA PATIENTS | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18261953 | COMPOSITION AND METHOD FOR HIGH-MULTIPLEXED GENOME ENGINEERING USING SYNTHETIC CRISPR ARRAYS | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18050071 | HIGHLY SPECIFIC CIRCULAR PROXIMITY LIGATION ASSAY | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 18601981 | METHODS AND KITS FOR PREPARING A SAMPLE COMPRISING ONE OR MORE RNA MOLECULES FOR SEQUENCING | Non-Final OA | The Hong Kong University of Science and Technology |
| 17929062 | ASSESSMENT OF MELANOMA THERAPY RESPONSE | Final Rejection | UNIVERSITY OF UTAH RESEARCH FOUNDATION |
| 18289859 | A Genotypic Assay To Subspeciate Mycobacterium Abscessus Complex Strains And Determine Macrolide Resistance | Non-Final OA | Rutgers, The State University of New Jersey |
| 18565970 | CHARACTERIZATION AND TREATMENT OF ASTHMA | Non-Final OA | The University of Chicago |
| 17436496 | COMPOSITIONS AND METHODS OF LABELING NUCLEIC ACIDS AND SEQUENCING AND ANALYSIS THEREOF | Final Rejection | King Abdullah University of Science and Technology |
| 18570006 | METHODS OF USING SOMATIC HLA-I LOH TO PREDICT RESPONSE OF IMMUNE CHECKPOINT INHIBITOR-TREATED PATIENTS WITH LUNG CANCER | Final Rejection | Foundation Medicine, Inc. |
| 18413996 | CONCURRENT SEQUENCING OF FORWARD AND REVERSE COMPLEMENT STRANDS ON CONCATENATED POLYNUCLEOTIDES FOR METHYLATION DETECTION | Non-Final OA | Illumina, Inc. |
| 18566369 | IDENTIFYING NUCLEOTIDES USING CHANGES IN IMPEDANCE BETWEEN ELECTRODES | Non-Final OA | Illumina, Inc. |
| 17747603 | MULTI-OMIC ANALYSIS OF EXTRACELLULAR VESICLES IN MONODISPERSE DROPLETS | Final Rejection | ILLUMINA, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy0.0% of resolved applications examined by Jessica Gray were allowed (13 resolved cases), compared with 41.2% across Art Unit 1682 over the last five years.
This examiner's interview lift is +0.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Jessica Gray took 1,370 days on average from filing to allowance.
Jessica Gray examines applications in Art Unit 1682 in Tech Center 1600 (Biotechnology & Pharmaceuticals).